Ligand validation:3EJQ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3EJQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EJQ_NAG_A_1046	2%	35%	0.362	0.643	0.59	1.95	-	2	1	0	100%	0.9333
3DDF_NAG_A_2001	19%	19%	0.269	0.867	0.81	2.62	-	8	4	0	100%	0.9333
1HWW_NAG_A_1101	13%	70%	0.258	0.799	0.48	0.68	-	1	0	0	100%	0.9333
1TQU_NAG_A_1046	11%	48%	0.281	0.802	0.99	1.01	1	1	2	1	100%	0.9333
3D50_NAG_A_1046	9%	33%	0.277	0.774	0.76	1.86	-	3	0	0	100%	0.9333
1R33_NAG_A_1046	9%	38%	0.336	0.829	0.95	1.46	1	2	1	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.